Amicus Therapeutics, Inc. (FOLD) SEC Filing 8-K Material Event for the period ending Thursday, June 27, 2019

Amicus Therapeutics Inc

CIK: 1500375 Ticker: FOLD

View differences made from one to another to evaluate Amicus Therapeutics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Amicus Therapeutics Inc.


Assess how Amicus Therapeutics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Amicus Therapeutics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: FOLD
CIK: 1178879
Form Type: 8-K Corporate News
Accession Number: 0001178879-19-000054
Submitted to the SEC: Thu Jun 27 2019 4:33:49 PM EST
Accepted by the SEC: Thu Jun 27 2019
Period: Thursday, June 27, 2019
Industry: Pharmaceutical Preparations
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: